Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis
BJS Open · 03.01.2024 · 8 (1)
DOI: 10.1093/bjsopen/zrad158 ↗Kurz gefasst
Metaanalyse in der Zeitschrift BJS Open, online erschienen am 07.02.2024. Verfasst von Pierluigi Romano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncological and Gastroenterological Sciences, Padua University Hospital, Padua, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Radiofrequency Ablation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The 2022 Barcelona Clinic Liver Cancer (BCLC) algorithm does not recommend liver resection (LR) in BCLC A patients with oligo-nodular (two or three nodules ≤3 cm) hepatocellular carcinoma (HCC). This sharply contrasts with the therapeutic hierarchy concept, implying a precise treatment order exists within each BCLC stage. This study aimed to compare the outcomes of LR versus radiofrequency ablation (RFA) or trans-arterial chemoembolization (TACE) in BCLC A patients.
Methods
A meta-analysis adhering to PRISMA guidelines and the Cochrane Handbook was performed. All RCT, cohort and case–control studies that compared LR versus RFA or TACE in oligo-nodular BCLC A HCC published between January 2000 and October 2023 were comprehensively searched on PubMed, Embase, the Cochrane Library and China Biology Medicine databases. Primary outcomes were overall survival (OS) and disease-free survival (DFS) at 3 and 5 years. Risk ratio (RR) was computed as a measure of treatment effect (OS and DFS benefit) to calculate common and random effects estimates for meta-analyses with binary outcome data.
Results
2601 patients from 14 included studies were analysed (LR = 1227, RFA = 686, TACE = 688). There was a significant 3- and 5-year OS benefit of LR over TACE (RR = 0.55, 95% c.i. 0.44 to 0.69, P < 0.001 and RR 0.57, 95% c.i. 0.36 to 0.90, P = 0.030, respectively), while there was no significant 3- and 5-year OS benefit of LR over RFA (RR = 0.78, 95% c.i. 0.37 to 1.62, P = 0.452 and RR 0.74, 95% c.i. 0.50 to 1.09, P = 0.103, respectively). However, a significant 3- and 5-year DFS benefit of LR over RFA was found (RR = 0.70, 95% c.i. 0.54 to 0.93, P = 0.020 and RR 0.82, 95% c.i. 0.72 to 0.95, P = 0.015, respectively). A single study comparing LR and TACE regarding DFS showed a significant superiority of LR. The Newcastle–Ottawa Scale quality of studies was high in eight (57%) and moderate in six (43%).
Conclusions
In BCLC A oligo-nodular HCC patients, LR should be preferred to RFA or TACE (therapeutic hierarchy concept). Additional comparative cohort studies are urgently needed to increase the certainty of this evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical Oncological and Gastroenterological Sciences, Padua University Hospital, Padua, Italy.
- Department of Biology, University of Padua, Padua, Italy.
- Bari University Hospital, Policlinico di Bari Ospedale Giovanni XXIII, U.O.S.D. Hepatobiliary Surgery, Bari, Italy.
ORCID-Profile: Pierluigi Romano, Ilaria Billato, Giovanni Marchegiani, Alessandro Vitale, Umberto Cillo
Zitieren
APA
Romano, P., Busti, M., Billato, I., D'Amico, F., Marchegiani, G., Pelizzaro, F., Vitale, A., & Cillo, U. (2024). Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis. BJS Open, 8(1). https://doi.org/10.1093/bjsopen/zrad158
Vancouver
Romano P, Busti M, Billato I, D'Amico F, Marchegiani G, Pelizzaro F, et al. Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis. BJS Open. 2024;8(1). doi:10.1093/bjsopen/zrad158
BibTeX
@article{Romano2024,
author = {Romano, Pierluigi and Busti, Marco and Billato, Ilaria and D'Amico, Francesco and Marchegiani, Giovanni and Pelizzaro, Filippo and Vitale, Alessandro and Cillo, Umberto},
title = {Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis},
journal = {BJS Open},
year = {2024},
volume = {8},
number = {1},
doi = {10.1093/bjsopen/zrad158}
}
EUVIMED